KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Working Capital Changes (2016 - 2025)

Sarepta Therapeutics (SRPT) has 13 years of Other Working Capital Changes data on record, last reported at $41.9 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 7.17% year-over-year to $41.9 million; the TTM value through Dec 2025 reached $72.1 million, up 644.64%, while the annual FY2025 figure was $72.1 million, 644.64% up from the prior year.
  • Other Working Capital Changes reached $41.9 million in Q4 2025 per SRPT's latest filing, up from -$7.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $122.7 million in Q2 2025 and bottomed at -$89.7 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$9.9 million, with a median of -$22.1 million recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: crashed 425.07% in 2022, then skyrocketed 1122.15% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$36.5 million in 2021, then skyrocketed by 38.29% to -$22.5 million in 2022, then crashed by 298.84% to -$89.7 million in 2023, then surged by 150.26% to $45.1 million in 2024, then decreased by 7.17% to $41.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $41.9 million in Q4 2025, -$7.1 million in Q3 2025, and $122.7 million in Q2 2025.